In vivo absolute quantification of striatal and extrastriatal D2/3 receptors with [123I]epidepride SPECT
Abstract Background [123I]epidepride is a high-affinity radiotracer used in single-photon emission computed tomography (SPECT) imaging of the D2/3 receptors. It binds with high affinity to striatal and extrastriatal receptors. Nevertheless, its slow kinetics in the striatum impedes quantification in...
Main Authors: | Stergios Tsartsalis, Benjamin B. Tournier, Philippe Millet |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-06-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-020-00650-0 |
Similar Items
-
Forced degradation behavior of epidepride and development of a stability-indicating method based on liquid chromatography–mass spectrometry
by: Wei-Hsi Chen, et al.
Published: (2014-06-01) -
Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
by: Nicolas Nicastro, et al.
Published: (2020-05-01) -
Dosimetry estimation of SPECT/CT for iodine 123-labeled metaiodobenzylguanidine in children
by: Aida Mhiri, et al.
Published: (2015-09-01) -
Evaluation of Iodine-123 and Iodine-131 SPECT activity quantification: a Monte Carlo study
by: Michaella Morphis, et al.
Published: (2021-08-01) -
Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
by: Eun Hye Jeong, et al.
Published: (2018-12-01)